Our study now shows that if you are in a subgroup of long Covid patients who have autoantibodies circulating in your body, you may be a good candidate for these drugs." A commentary in Cell noted that the two studies provide compelling evidence that autoantibodies directly contribute to symptom generation in a subset of long Covid patients, while cautioning that neither provides definitive proof of a single central mechanism behind the condition
April 2, 2025: 164 More Federal Lawsuits Filed in Federal Case Involving Mounjaro and Other GLP-1 Drugs There are 1,685 active cases against Eli Lilly, the manufacturer of Mounjaro, and other GLP-1 drug makers as part of the federal group litigation against these drug companies
It depends on what risks you're willing to accept
More serious but less common risks include pancreatitis, gallbladder problems, kidney issues and, based on animal studies, a theoretical risk of thyroid C-cell tumours
Retatrutide will likely cost slightly more at launch given its added complexity, but manufacturer savings programs could bring both to similar out-of-pocket costs for eligible patients